{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:35:30Z","timestamp":1774647330640,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12223-018-0650-z","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T03:54:56Z","timestamp":1537934096000},"page":"237-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of drug resistance mutations in patients with chronic hepatitis B"],"prefix":"10.1007","volume":"64","author":[{"given":"Sema","family":"Alacam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuran","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayfer","family":"Yolcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Onel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alp","family":"Atasoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahattin","family":"Kaymakoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Agacfidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"650_CR1","doi-asserted-by":"publisher","first-page":"e0170362","DOI":"10.1371\/journal.pone.0170362","volume":"12","author":"HJ Ahn","year":"2017","unstructured":"Ahn HJ, Song MJ, Jang JW, Bae SH, Choi JY, Yoon SK (2017) Treatment efficacy and safety of tenofovir-based therapy in chronic hepatitis B: a real life cohort study in Korea. PLoS One 12:e0170362. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0170362","journal-title":"PLoS One"},{"key":"650_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.5578\/mb.5625","volume":"47","author":"S Aydogan","year":"2013","unstructured":"Aydogan S et al (2013) Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year. Mikrobiyol Bul 47:472\u2013481","journal-title":"Mikrobiyol Bul"},{"key":"650_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jviromet.2016.08.016","volume":"237","author":"W Chantratita","year":"2016","unstructured":"Chantratita W, Song KS, Pongthanapisith V, Thongbaiphet N, Angkanavin K, Nimse SB, Sonawane MD, Kim T (2016) HBV\/4DR 9G test and its comparison with INNO-LiPA HBV multi-DR test for the detection of drug-resistant. Hepatitis B virus. J Virol Methods 237:58\u201363. \n                    https:\/\/doi.org\/10.1016\/j.jviromet.2016.08.016","journal-title":"J Virol Methods"},{"key":"650_CR4","first-page":"29","volume":"38","author":"MA Francesco De","year":"2015","unstructured":"De Francesco MA et al (2015) Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine. New Microbiol 38:29\u201337","journal-title":"New Microbiol"},{"key":"650_CR5","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/j.clinre.2012.01.003","volume":"36","author":"J Dupouey","year":"2012","unstructured":"Dupouey J, Gerolami R, Solas C, Colson P (2012) Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy. Clin Res Hepatol Gastroenterol 36:e26\u2013e28. \n                    https:\/\/doi.org\/10.1016\/j.clinre.2012.01.003","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"650_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5578\/mb.6192","volume":"47","author":"K Ergunay","year":"2013","unstructured":"Ergunay K et al (2013) Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases. Mikrobiyol Bul 47:628\u2013635","journal-title":"Mikrobiyol Bul"},{"key":"650_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/jmv.23916","volume":"86","author":"S Ezzikouri","year":"2014","unstructured":"Ezzikouri S, Ozawa M, Kohara M, Elmdaghri N, Benjelloun S, Tsukiyama-Kohara K (2014) Recent insights into hepatitis B virus-host interactions. J Med Virol 86:925\u2013932. \n                    https:\/\/doi.org\/10.1002\/jmv.23916","journal-title":"J Med Virol"},{"key":"650_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/infdis\/jiv363","volume":"213","author":"LE Hermans","year":"2016","unstructured":"Hermans LE, Svicher V, Pas SD, Salpini R, Alvarez M, Ben Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, K\u00f6se S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-St\u00f6ckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Weis N, Yalcinkaya T, Lepej SZ, Perno C, Boucher CA, Wensing AM, HEPVIR Working Group of the European Society for Translational Antiviral Research (2016) Combined analysis of the prevalence of drug-resistant hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE). J Infect Dis 213:39\u201348. \n                    https:\/\/doi.org\/10.1093\/infdis\/jiv363","journal-title":"J Infect Dis"},{"key":"650_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3760\/cma.j.issn.1007-3418.2016.01.007","volume":"24","author":"B Jiang","year":"2016","unstructured":"Jiang B, Dai CY, Li XM, Su R, Xu J, Cao Y, Hou W, Lu W (2016) Drug-resistant mutations in hepatitis B virus found in chronic HBV carriers using PCR sequencing technology. Zhonghua Gan Zang Bing Za Zhi 24:36\u201339. \n                    https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2016.01.007","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"650_CR10","first-page":"237","volume":"44","author":"R Kalayc\u0131","year":"2010","unstructured":"Kalayc\u0131 R, Alt\u0131ndi\u015f M, G\u00fclamber C, Demirt\u00fcrk N, Akcan Y, Demirdal T (2010) Kronik hepatit B ve hepatit C\u2019li hastalarda genotip da\u011f\u0131l\u0131m\u0131 ve hepatit B olgular\u0131nda diren\u00e7 paterninin ara\u015ft\u0131r\u0131lmas\u0131. Mikrobiyol Bul 44:237\u2013243","journal-title":"Mikrobiyol Bul"},{"key":"650_CR11","doi-asserted-by":"publisher","unstructured":"K\u0131rdar S, Ya\u015fa MH, Ayd\u0131n N, G\u00fcltekin Korkmazgil B (2016) Detection of resistance mutations in chronic hepatitis B patients receiving lamivudine therapy using molecular method. T\u00fcrk Mikrobiyol Cem Derg \n                    https:\/\/doi.org\/10.5222\/tmcd.2016.135","DOI":"10.5222\/tmcd.2016.135"},{"key":"650_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4274\/vhd.42204","volume":"21","author":"S Kose","year":"2015","unstructured":"Kose S, Turken M, Gul S (2015) Evaluation of lamivudine resistance assay using a molecular method in patients with chronic hepatitis B. Viral Hepat J 21:17\u201319","journal-title":"Viral Hepat J"},{"key":"650_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/jvh.12732","volume":"24","author":"AS Lok","year":"2017","unstructured":"Lok AS, Ganova-Raeva L, Cloonan Y, Punkova L, Lin HHS, Lee WM, Ghany MG, the Hepatitis B Research Network (HBRN) (2017) Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. J Viral Hepat 24:1032\u20131042. \n                    https:\/\/doi.org\/10.1111\/jvh.12732","journal-title":"J Viral Hepat"},{"key":"650_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jgar.2016.10.012","volume":"8","author":"T Meng","year":"2017","unstructured":"Meng T, Shi X, Gong X, Deng H, Huang Y, Shan X, Shan Y, Huang A, Long Q (2017) Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010-2014). J Glob Antimicrob Resist 8:74\u201381. \n                    https:\/\/doi.org\/10.1016\/j.jgar.2016.10.012","journal-title":"J Glob Antimicrob Resist"},{"key":"650_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2222-1808(16)61079-4","volume":"6","author":"M Motahar","year":"2016","unstructured":"Motahar M, Arabzadeh SA, Mollaei H, Iranmanesh Z, Nikpour N, Soleimani F (2016) Evaluation of HBV resistance to tenofovir in patients with chronic hepatitis B using ZNA probe assay in Kerman, southeast of Iran. Asian Pac J Trop Dis 6:513\u2013516. \n                    https:\/\/doi.org\/10.1016\/s2222-1808(16)61079-4","journal-title":"Asian Pac J Trop Dis"},{"key":"650_CR16","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.3748\/wjg.v21.i23.7084","volume":"21","author":"M Ohno","year":"2015","unstructured":"Ohno M, Otsuka M, Kishikawa T, Yoshikawa T, Takata A, Koike K (2015) Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA. World J Gastroenterol 21:7084\u20137088. \n                    https:\/\/doi.org\/10.3748\/wjg.v21.i23.7084","journal-title":"World J Gastroenterol"},{"key":"650_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3748\/wjg.15.753","volume":"15","author":"R Pastor","year":"2009","unstructured":"Pastor R, Habersetzer F, Fafi-Kremer S, Doffo\u00ebl M, Baumert TF, Gut JP, Stoll-Keller F, Schvoerer E (2009) Hepatitis B virus mutations potentially conferring adefovir\/tenofovir resistance in treatment-naive patients. World J Gastroenterol 15:753\u2013755. \n                    https:\/\/doi.org\/10.3748\/wjg.15.753","journal-title":"World J Gastroenterol"},{"key":"650_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.5812\/kowsar.1735143X.775","volume":"11","author":"M Sayan","year":"2011","unstructured":"Sayan M, Akhan SC, Senturk O (2011) Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies. Hepat Mon 11:835\u2013842. \n                    https:\/\/doi.org\/10.5812\/kowsar.1735143X.775","journal-title":"Hepat Mon"},{"issue":"Suppl 3","key":"650_CR19","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/j.ijid.2009.11.039","volume":"14","author":"M Sayan","year":"2010","unstructured":"Sayan M, Senturk O, Akhan SC, Hulagu S, Cekmen MB (2010) Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B. Int J Infect Dis 14(Suppl 3):e136\u2013e141. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2009.11.039","journal-title":"Int J Infect Dis"},{"key":"650_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/v9050125","volume":"9","author":"S Schreiner","year":"2017","unstructured":"Schreiner S, Nassal M (2017) A role for the host DNA damage response in hepatitis B virus cccDNA formation-and beyond? Viruses 9:125. \n                    https:\/\/doi.org\/10.3390\/v9050125","journal-title":"Viruses"},{"key":"650_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15406\/jlrdt.2016.02.00037","volume":"2","author":"V Sharma","year":"2016","unstructured":"Sharma V (2016) First report of primary tenofovir resistance in a hepatitis B viral hepatitis patient from India without human immunodeficiency virus co-infection. J Liver Res Disord Ther 2:5. \n                    https:\/\/doi.org\/10.15406\/jlrdt.2016.02.00037","journal-title":"J Liver Res Disord Ther"},{"key":"650_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jhep.2017.03.027","volume":"67","author":"E Shirvani-Dastgerdi","year":"2017","unstructured":"Shirvani-Dastgerdi E, Winer BY, Celi\u00e0-Terrassa T, Kang Y, Tabernero D, Yagmur E, Rodr\u00edguez-Fr\u00edas F, Gregori J, Luedde T, Trautwein C, Ploss A, Tacke F (2017) Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy. J Hepatol 67:246\u2013254. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2017.03.027","journal-title":"J Hepatol"},{"key":"650_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.21037\/atm.2016.09.19","volume":"4","author":"F Tacke","year":"2016","unstructured":"Tacke F, Kroy DC (2016) Treatment for hepatitis B in patients with drug resistance. Ann Transl Med 4:334. \n                    https:\/\/doi.org\/10.21037\/atm.2016.09.19","journal-title":"Ann Transl Med"},{"key":"650_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","volume":"21","author":"N Tozun","year":"2015","unstructured":"Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, Kaymakoglu S, Ergonul O (2015) Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 21:1020\u20131026. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2015.06.028","journal-title":"Clin Microbiol Infect"},{"key":"650_CR25","unstructured":"WHO (2017) Hepatitis B fact sheet. \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/\n                    \n                  . Accessed 21.11.2017"},{"key":"650_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/hep4.1022","volume":"1","author":"N Yamada","year":"2017","unstructured":"Yamada N, Sugiyama R, Nitta S, Murayama A, Kobayashi M, Okuse C, Suzuki M, Yasuda K, Yotsuyanagi H, Moriya K, Koike K, Wakita T, Kato T (2017) Resistance mutations of hepatitis B virus in entecavir-refractory patients. Hepatol Commun 1:110\u2013121. \n                    https:\/\/doi.org\/10.1002\/hep4.1022","journal-title":"Hepatol Commun"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12223-018-0650-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-018-0650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-018-0650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T23:11:56Z","timestamp":1569453116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12223-018-0650-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1007\/s12223-018-0650-z","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"24 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained by Ethics Committee of Istanbul University, Istanbul Faculty of Medicine (reference number: 2017\/652\/11).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}